COMPANY PROFILE · /chai-discovery
C
Chai Discovery
AI-native biotech company that predicts and reprograms interactions between biochemical molecules for drug discovery. Builds foundation models tuned to design novel antibodies and therapeutic molecules with improved developability properties, tackling historically hard-to-drug targets.
Fresh · 9d ago
Latest valuation
$1.3B
Annual Recurring Revenue
—
Headcount
—
Funding total
$225M+
OVERVIEW
Series B ($130M, Dec 2025) follows Series A ($70M, Aug 2025). Chai 2 model achieves 100x improvement over prior computational antibody design methods. Early-stage biotech AI with exceptional velocity and institutional backing.
Status
active
Tier
master-list
Profitability
—
Pricing
enterprise
FUNDING HISTORY · 0
No funding rounds on file.
PRODUCTS · 0
No products catalogued yet. Press Refresh above to ask the research agent.
TEAM · 0 key people
No people linked.
SOURCES · 0 cited
No citations stored yet. Run the research agent to attach per-claim sources.